Embed Notice

@danilo Pharmaceuticals are dirt cheap to manufacture. The bottom fell out of the manufacturing cost for renewables a decade ago and we still haven't hit ground.

To answer my own question, I think the difference is that venture funding has produced a binge/purge staffing dynamic in tech that has nothing to do with interest rates. That binge/purge was the main driver suppressing labor power, and pandemic lockdowns broke the cycle.